Prospective randomized trial comparing two doses of rabbit anti‐thymocyte globulin in patients with severe aplastic anaemia-Reference-Cited by-同舟云学术

Prospective randomized trial comparing two doses of rabbit anti‐thymocyte globulin in patients with severe aplastic anaemia

Published:2019-06-17 Issue:2 Volume:187 Page:227-237
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Narita Atsushi¹^ORCID,Zhu Xiaofan²,Muramatsu Hideki¹,Chen Xiaojuan²,Guo Ye²,Yang Wenyu²,Zhang Jingliao²,Liu Fang²,Jang Jun H.³,Kook Hoon⁴,Kim Hawk⁵^ORCID,Usuki Kensuke⁶,Yamazaki Hirohito⁷,Takahashi Yoshiyuki¹,Nakao Shinji⁸,Wook Lee Jong⁹,Kojima Seiji¹^ORCID,

Affiliation:

1. Department of Paediatrics Nagoya University Graduate School of Medicine Nagoya Japan

2. Department of Paediatrics Institute of Haematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Tianjin People’s Republic of China

3. Department of Haematology Oncology Samsung Medical Centre, Sungkyunkwan University School of Medicine Seoul Republic of Korea

4. Department of Paediatrics Chonnam National University Hwasun Hospital, Chonnam National University Medical School Hwasun Republic of Korea

5. Division of Haematology Gachon University Gil Medical Centre, Gachon University College of Medicine Incheon Republic of Korea

6. Department of Haematology NTT Medical Centre Tokyo Tokyo Japan

7. Division of Transfusion Medicine Kanazawa University Hospital Kanazawa Japan

8. Department of Haematology and Respirology Kanazawa University Graduate School of Medical Sciences Kanazawa Japan

9. Department of Haematology Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea Seoul Republic of Korea

Funder

Sanofi

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.16055

Reference30 articles.

1. Population Pharmacokinetic Modeling of Thymoglobulin® in Children Receiving Allogeneic-Hematopoietic Cell Transplantation: Towards Improved Survival Through Individualized Dosing

2. Efficacy of rabbit anti-thymocyte globulin in severe aplastic anemia

3. Comparison between horse and rabbit antithymocyte globulin as first-line treatment for patients with severe aplastic anemia: a single-center retrospective study

4. Predictors of early mortality after rabbit antithymocyte globulin as first-line treatment in severe aplastic anemia

5. Treatment of acquired severe aplastic anemia: Bone marrow transplantation compared with immunosuppressive therapy-the European group for blood and marrow transplantation experience

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progress in medical therapy in aplastic anemia: why it took so long?;International Journal of Hematology;2024-02-26

2. Single-cell RNA Sequencing Reveals Novel Cellular Factors for Response to Immunosuppressive Therapy in Aplastic Anemia;HemaSphere;2023-10-27

3. Repeated immunosuppressive rabbit antithymocyte globulin therapy for adult patients with relapsed or refractory aplastic anemia;European Journal of Haematology;2023-08-07

4. Recent advances in the diagnosis and treatment of pediatric acquired aplastic anemia;International Journal of Hematology;2023-03-03

5. First-line immunosuppressive therapy with rATG and CsA for severe aplastic anemia: 15 years’ experience;Annals of Hematology;2022-09-24